Baird analysts cited lowered investor expectations for orthopedic end market trends and moderating earnings expectations following its Biomet acquisition. Baird raised its price target to $125 from $110 on Zimmer shares. The stock price is expected to reach $125.80 in the short term.
Zimmer shares sank 4.17 percent during the past week and dropped 0.44 percent in the past month. The 52-week low of the shares is $90.48.
More articles on devices:
K2M sets follow-on offering at $18.75 per share — 5 things to know
Implanet’s JAZZ technology receives intellectual patent protection in Europe
FTC makes second request for additional information on Wright Medical-Tornier merger — 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
